Acetaminophen (Paracetamol) updated on 09-20-2024

Respiratory system anomalies

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S18507
R78642
Broe (Controls unexposed, general pop), 2025 Respiratory malformations 1st trimester population based cohort retrospective unexposed (general population or NOS) excluded Adjustment: Yes Paracetamol use: prescription or medical files 1.93 [1.12;3.32]
excluded (control group)
14/8,590   358/471,855 372 8,590
ref
S18508
R78643
Broe (Controls unexposed, sick), 2025 Respiratory malformations 1st trimester population based cohort retrospective unexposed, sick Adjustment: Yes Paracetamol use: prescription or medical files 2.32 [1.03;5.24] 14/8,590   10/14,817 24 8,590
ref
S18505
R78747
Rebordosa a, 2008 Respiratory malformations 1st trimester prospective cohort unexposed (general population or NOS) Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy 1.06 [0.66;1.68] 29/26,424   62/61,718 91 26,424
ref
Total 2 studies 1.46 [0.69;3.10] 115 35,014
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Broe (Controls unexposed, sick), 2025Broe, 2025 1 2.32[1.03; 5.24]248,59041%ROB confusion: seriousROB selection: moderateROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: critical Rebordosa a, 2008Rebordosa a, 2008 1.06[0.66; 1.68]9126,42459%ROB confusion: seriousROB selection: moderateROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Total (2 studies) I2 = 63% 1.46[0.69; 3.10]11535,0140.55.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.46[0.69; 3.10]11535,01463%NABroe (Controls unexposed, sick), 2025 Rebordosa a, 2008 2 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.06[0.66; 1.69]9126,424 -NARebordosa a, 2008 1 unexposed, sickunexposed, sick 2.32[1.03; 5.23]248,590 -NABroe (Controls unexposed, sick), 2025 1 Tags Adjustment   - Yes  - Yes 1.46[0.69; 3.10]11535,01463%NABroe (Controls unexposed, sick), 2025 Rebordosa a, 2008 2 Paracetamol use   - maternal ITW/questionnaires during ...  - maternal ITW/questionnaires during pregnancy 1.06[0.66; 1.69]9126,424 -NARebordosa a, 2008 1   - prescription or medical files  - prescription or medical files 2.32[1.03; 5.23]248,590 -NABroe (Controls unexposed, sick), 2025 1 All studiesAll studies 1.46[0.69; 3.10]11535,01463%NABroe (Controls unexposed, sick), 2025 Rebordosa a, 2008 20.55.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 18507

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.41[0.78; 2.53]46335,01463%NABroe (Controls unexposed, general pop), 2025 Rebordosa a, 2008 2 unexposed, sick controlsunexposed, sick controls 2.32[1.03; 5.23]248,590 -NABroe (Controls unexposed, sick), 2025 10.510.01.0